Could Albumin Be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barre Syndrome? Reply

Willem Jan Fokkink, B.C. Jacobs

Research output: Contribution to journal › Article › Academic › peer-review

Research programs

@article{8d0c5ca5334b423c8bc548321a679506,

title = "Could Albumin Be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barre Syndrome? Reply",

author = "Fokkink, {Willem Jan} and B.C. Jacobs",

year = "2017",

doi = "10.1001/jamaneurol.2017.0566",

language = "Undefined/Unknown",

volume = "74",

pages = "872--872",

journal = "JAMA Neurology",

issn = "2168-6149",

publisher = "American Medical Association",

number = "7",

}

TY - JOUR

T1 - Could Albumin Be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barre Syndrome? Reply

AU - Fokkink, Willem Jan

AU - Jacobs, B.C.

PY - 2017

Y1 - 2017

U2 - 10.1001/jamaneurol.2017.0566

DO - 10.1001/jamaneurol.2017.0566

M3 - Article

C2 - 28505236

SN - 2168-6149

VL - 74

SP - 872

EP - 872

JO - JAMA Neurology

JF - JAMA Neurology

IS - 7

ER -